
    
      Subjects will receive oral avatrombopag once daily for 5 days beginning on Day 1, followed by
      a wait period prior to the procedure, which will occur on Day 10 to 13. The Follow-up Period
      will include 2 visits; 7 days post-procedure and 30 days after last dose.
    
  